Biotech Companies

Biotech companies have beyond tripled in the past few decades. The demand for research and development of new medicines and techniques in this field of biology is the primary cause. Private investors from all over the world have put money into these multimillion dollar companies as an investment in stock that continues to grow. The number of biotech companies has increased greatly in the United States as well as surprisingly India. Some other smaller nations such as Switzerland, have a good number but can’t compete with the advancement of U.S. These companies are expanding their research center and staff because of new developments and the need for more workers to run such giant companies.
Such developments and advancements in the field have led to the growth of their stock value. These values have climbed exponentially causing a growth in the number of people purchasing stock in biotech left and right. Who would’ve thought that this was the field to put your money into to watch it grow drastically, twenty years ago? Some of the world’s largest biotech companies include Amgen, Calgene, CSL, Genzyme, Actelion, PDL BioPharma, Serono, Biogen Idec, Gilead Services, and Cephalon. If the advancement of biology in technology continues on its path who knows how many more companies we will see emerge in the next decade. Perhaps we will be able to see countless biotech companies in every state, and eventually one in every region of the state. The demand for these research centers is growing, and the space needed is there. It’s only a matter of time before investors and institutions purchase more land and property in which to set these companies up. This may not be necessarily a bad thing because with the recession today, thousands of more available jobs couldn’t possibly be a bad thing. The products that are coming out of these facilities, and the medicines created are helping better the way of human life, so on top it definitely seems like a beneficial outcome for all. Some people may argue that these giants are taking over their state, city , or town, but who is to argue when these jobs are necessary and the product of these companies is beneficiary to theirs and everyone’s health. These companies also balance out our stocks because once they build up to where they want to be, sometimes they sell to larger pharmaceutical companies at high prices. The people that were hurt most during this recession was New York’s Wall Street stock market workers. Perhaps with the recent selling and buying of biotech companies in the last month, the stocks will rise and some people that were previously laid off can come back to their jobs. Biotech companies are a great part of the economy and a great part of our improvement of our way of life, with their developments we will see their growth’s positive impact on our world. We hope to see a continued growth pattern in them, as well as in their research.